Our research showed that WBP2 was downregulated in the liver of a mouse model of NAFLD; overexpression of WBP2 in the mouse liver inhibited steatohepatitis and IR caused by a high-fat diet (HFD). Here, WBP2 is linked to metabolic dysfunction-associated steatotic liver disease.